Sleep apnea is a respiratory disorder characterized by periods of apnea (a cessation in breathing) and hypopnea (disruptively shallow breathing or slow respiratory rate) during sleep. During either of these “apneic” events, breathing ceases long enough to allow several normal breaths to be missed. In order to be considered an apneic event, there has to be a 10 second interval between breaths and neurological arousal and/or blood oxygen desaturation, or both. In most cases, the sufferer is unaware of experiencing such an event at the time and often simply falls back asleep afterwards.
Obstructive sleep apnea is defined as an interruption in breathing despite respiratory effort from the patient. The patient’s nervous system stimulates the muscles involved in breathing, but a physical obstruction prevents the airway from opening. In obstructive sleep apnea cases, relaxation of the muscles during sleep allows the wall of soft tissue in the throat to partially or completely cover the airway, causing an apneic event. Severe, chronic cases of OSA are especially dangerous due to the risks associated with sleep deprivation (including dangerous driving), low blood oxygen, and more serious complications including a form of congestive heart failure called cor pulmonale.
The market for sleep therapy devices, which includes both positive airway pressure equipment and the patient interfaces used in conjunction with these devices, is the largest market in the total Anesthesia, Respiratory and Sleep (ARS) Management Devices market, accounting for almost half of it. The widespread use of these devices is largely due to an increasing awareness of sleep apnea and the risks of leaving the condition untreated, and along with the ageing of the European population, will give rise to a greater need for capital equipment, diagnostic devices and the disposable products that are integral to their use.
For more information on the ARS market, please access our website to acquire a free table of contents or free synopsis of the reports available. Our global series of reports on this market covers the U.S. and 15 countries in Europe and includes segments such as anesthesia delivery units, anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy, therapeutic obstructive sleep apnea devices, and sleep diagnostic devices. For a promotional pricing on our latest published report, European Markets for Anesthesia, Respiratory, and Sleep Management Devices, please get in touch at [email protected]